A randomized, double-blind, placebo-controlled, two arm cross-over study to determine whether a specific combination of Andrographis paniculata and Withania somnifera can be regarded as a safe and effective treatment for cognitive deficits.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
16
Combination of Andrographis paniculata and Withania somnifera
Visually identical placebo capsule
Clinical Labors of NeuroCode AG
Wetzlar, Germany
Change over time in neural electrical activity of the brain as measured by quantitative-topographic EEG for herbal treatment group versus placebo
Responses of electric brain activity as spectral power in 17 different brain regions within 6 specially defined frequency ranges (delta, theta, alpha1, alpha2, beta1 and beta2) during the test of cognitive performance: d2-test for attention (d2-Test), memory test (ME-Test), concentration-performance-test with financial reward (CPT-Test).
Time frame: Four weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.